financetom
Business
financetom
/
Business
/
Update: Wallbridge Mining Shares Down 10%; Launches Offering of Up to C$15 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Wallbridge Mining Shares Down 10%; Launches Offering of Up to C$15 Million
Oct 15, 2025 9:04 AM

11:35 AM EDT, 10/15/2025 (MT Newswires) -- Wallbridge Mining ( WLBMF ) late Tuesday said it is launching a public offering of charity flow-through units and hard dollar units to raise up to C$15 million in gross proceeds.

Wallbridge said it has entered into an agreement with BMO Capital Markets as sole bookrunner on behalf of a syndicate of agents for the offering.

The offering will be composed of 65 million charity flow-through units priced at $0.15 per unit for gross proceeds of up to $10 million; and 45 million hard dollar units priced at $0.11 per unit for gross proceeds of up to $5 million.

Each charity flow-through unit will consist of one common share issued on a flow-through basis and one common share purchase warrant. Each hard dollar unit will consist of one common share and one warrant.

Each warrant will entitle the holder to purchase one common share at an exercise price of $0.15 for a 36-month period after the offering closes.

The agents have been granted an option to purchase up to an additional 15% of the offering to cover over-allotments, exercisable at the offering price for a 30-day period after the offering closes.

Net proceeds will be used to advance Wallbridge's Fenelon and Martiniere projects and for general corporate purposes.

In connection with the offering, the company intends to notify Agnico Eagle Mines of its right to participate under a Dec. 6, 2019, participation agreement.

The offering is scheduled to close on Oct. 31, subject to the receipt of all necessary regulatory approvals.

Wallbridge's share price at last look fell 10.4% to $0.11 on the Toronto Stock Exchange in early Wednesday trading.

Price: 0.11, Change: -0.01, Percent Change: -10.00

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With FuelCell Energy Stock Today?
What's Going On With FuelCell Energy Stock Today?
Jul 11, 2024
FuelCell Energy Inc ( FCEL ) shares are trading higher. The company on Thursday highlighted a significant Korean market expansion milestone and provided some details from a recent event in Seoul. What Happened: FuelCell said it recently held an event in Seoul, reinforcing the company’s commitment to the Korean market and highlighting how its two differentiated carbonate and solid oxide...
Olaplex Holdings Names Catherine Dunleavy CFO, COO
Olaplex Holdings Names Catherine Dunleavy CFO, COO
Jul 11, 2024
08:55 AM EDT, 07/11/2024 (MT Newswires) -- Olaplex Holdings ( OLPX ) said Thursday that it has appointed Catherine Dunleavy as its chief financial officer and chief operating officer, effective Aug. 13. Dunleavy most recently served as president of Away, Olaplex ( OLPX ) said. Olaplex ( OLPX ) said it has also appointed Katie Gohman as its chief marketing...
ChargePoint Holdings Appoints CFO, Chief Development Officer; New Director Joins Board's Audit Committee
ChargePoint Holdings Appoints CFO, Chief Development Officer; New Director Joins Board's Audit Committee
Jul 11, 2024
08:46 AM EDT, 07/11/2024 (MT Newswires) -- ChargePoint Holdings ( CHPT ) said Thursday it has appointed Mansi Khetani as chief financial officer and Ash Chowdappa as chief development officer for software, effective earlier this week. Khetani had been the company's interim CFO since November, while Chowdappa was previously the senior vice president of software at HPE Aruba Networks. Additionally,...
Abeona Therapeutics Partners with Beacon Therapeutics to Develop Ophthalmic Gene Therapies
Abeona Therapeutics Partners with Beacon Therapeutics to Develop Ophthalmic Gene Therapies
Jul 11, 2024
08:46 AM EDT, 07/11/2024 (MT Newswires) -- Abeona Therapeutics ( ABEO ) said Thursday it entered into an exclusive agreement with Beacon Therapeutics to evaluate its patented AAV204 capsid to potentially develop and market gene therapies for specific ophthalmic conditions. Under the deal, Beacon Therapeutics has secured a 12-month evaluation period for AAV204 capsid for select ophthalmology indications and holds...
Copyright 2023-2026 - www.financetom.com All Rights Reserved